University of Southampton: Adding Antibody Treatment to Chemo Boosts Outcomes for Children With Rare Cancer
December 16, 2025
December 16, 2025
SOUTHAMPTON, England, Dec. 16 (TNSjou) -- The University of Southampton issued the following news:
* * *
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment, or that has relapsed, may benefit from adding antibody treatment to usual chemotherapy, according to new results from a clinical trial.
The BEACON phase 2 . . .
* * *
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment, or that has relapsed, may benefit from adding antibody treatment to usual chemotherapy, according to new results from a clinical trial.
The BEACON phase 2 . . .